Essential Pharma’s Acquisition of Ocular And Postpartum Therapies From Novartis

Federica Tiefenthaler
Tagged:

Lenz & Staehelin advised Essential Pharma in this transaction.Essential Pharma, a portfolio company of Gyrus Capital, has acquired on December 8, 2021, the worldwide rights –…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here